Sign up Australia
Proactive Investors - Run By Investors For Investors
Why invest in BCT?
Bluechiip: THE INVESTMENT CASE

Bluechiip: Access latest PPT from Proactive's CEO Sessions

Andrew McLellan discussed with investors wiresless tracking technology.
Bluechiip: Access latest PPT from Proactive's CEO Sessions
INVESTMENT OVERVIEW: BCT The Big Picture
Andrew McLellan, MD, bluechiip

Bluechiip's (ASX:BCT) managing director, Andrew McLellan, joined Proactive's CEO Sessions in Sydney on Tuesday 14th March and Melbourne on Wednesday 15th March.

Bluechiip has developed an IT based temperature and identification tracking solution for biosamples in the health and life sciences industry.

The company has a growing partner pipeline and growing revenues.

 

ACCESS THE FULL PRESENTATION HERE

 

View full BCT profile View Profile

Bluechiip Timeline

Newswire
August 11 2016
Newswire
December 15 2015
Newswire
September 16 2015
Newswire
August 28 2014

Related Articles

Mexican flag
March 26 2018
PLCs in emerging markets no longer have to find someone to promote their company to overseas investors
electric vehicle charging
July 04 2018
AMP wants to add 25 sites in Greater London and extend its reach into the North-West around Liverpool and Manchester
picture of trading screens
Thu
With an optimistic outlook on future earnings, the company expects to recommend its first dividend in the second half of the current financial year.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use